| dbo:abstract
|
- Acuitas Therapeutics Inc. is a Canadian biotechnology company based in Vancouver, British Columbia. The company was established in February 2009 to specialize in the development of delivery systems for nucleic acid therapeutics based on lipid nanoparticle (LNP) technology, a key component of the mRNA vaccines deployed for COVID-19. (en)
|
| dbo:foundedBy
| |
| dbo:headquarter
| |
| dbo:industry
| |
| dbo:thumbnail
| |
| dbo:type
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 24392 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:founded
|
- in Vancouver, British Columbia, Canada (en)
|
| dbp:founder
| |
| dbp:hqLocation
|
- Vancouver, British Columbia, Canada (en)
|
| dbp:industry
| |
| dbp:logo
|
- Acuitas Therapeutics logo.jpg (en)
|
| dbp:name
|
- Acuitas Therapeutics Inc. (en)
|
| dbp:type
| |
| dbp:website
| |
| dbp:wikiPageUsesTemplate
| |
| rdf:type
| |
| rdfs:comment
|
- Acuitas Therapeutics Inc. is a Canadian biotechnology company based in Vancouver, British Columbia. The company was established in February 2009 to specialize in the development of delivery systems for nucleic acid therapeutics based on lipid nanoparticle (LNP) technology, a key component of the mRNA vaccines deployed for COVID-19. (en)
|
| rdfs:label
|
- Acuitas Therapeutics (en)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:homepage
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
|
- Acuitas Therapeutics Inc. (en)
|
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
